Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Th1 cells (tissue)
Most Correlated Studies
- Th1 and Th17 CD4+ T cell lineages
- CD4+ Th1 cells at rest or activated and treated with BET protein inhibitor I-BET-762
- Egr2-dependent expression in T cell anergy
- Differentiating T helper Th1 and Th17 cells Malt1 knockout or wildtype
- CD4+ T cells activated ex vivo by antigen presenting cells or by anti-CD3/anti-CD28
Most Relevant Literature
- The emerging role of Th1 cells in atherosclerosis and its implications for therapy.
- Emedastine Inhibits Th1 and Th2 Cell Differentiation Mediated by Mast Cells.
- IL-10-producing Th1 cells possess a distinct molecular signature in malaria
- Intrinsic STING Switches off Pathogenetic Programs of Th1 Cells to Inhibit Colitis.
- Deficiency of Pink1 promotes the differentiation of Th1 cells.
Most Relevant Clinical Trials
- Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
- Th1, Th2, Th17 Phenotype in Urea Cycle Disorders
- Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
- Th1 Response to Influenza: Aging and Vaccine Efficacy
- Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer
